Gilead Sciences, Inc.
(NASDAQ : GILD)

( )
GILD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 0.25%75.181.0%$1750.73m
AMGNAmgen, Inc. -0.64%217.791.3%$925.22m
REGNRegeneron Pharmaceuticals, Inc. -0.92%507.642.6%$838.50m
BIIBBiogen, Inc. -0.64%314.921.5%$800.53m
VRTXVertex Pharmaceuticals, Inc. -0.49%248.451.9%$654.30m
MRNAModerna, Inc. 0.25%32.500.0%$511.91m
ILMNIllumina, Inc. -0.48%279.643.5%$489.45m
ALXNAlexion Pharmaceuticals, Inc. 4.05%98.562.0%$309.13m
AAgilent Technologies, Inc. 3.58%76.681.6%$228.40m
INCYIncyte Corp. -0.34%87.452.5%$220.29m
EXASEXACT Sciences Corp. 6.02%66.3721.0%$182.14m
SGENSeattle Genetics, Inc. -0.49%119.106.1%$160.52m
BMRNBioMarin Pharmaceutical, Inc. -0.64%79.094.3%$149.60m
NVAXNovavax, Inc. 1.86%17.50114.7%$138.18m
IMMUImmunomedics, Inc. -2.54%18.4311.9%$121.13m

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA.